Pharmacogenomics-guided policy in opioid use disorder (OUD) management: An ethnically-diverse case-based approach()

INTRODUCTION: Opioid use disorder (OUD) is characterized by a problematic pattern of opioid use leading to clinically-significant impairment or distress. Opioid agonist treatment is an integral component of OUD management, and buprenorphine is often utilized in OUD management due to strong clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Ettienne, Earl B., Chapman, Edwin, Maneno, Mary, Ofoegbu, Adaku, Wilson, Bradford, Settles-Reaves, Beverlyn, Clarke, Melissa, Dunston, Georgia, Rosenblatt, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Discussion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800559/
https://www.ncbi.nlm.nih.gov/pubmed/29450233
http://dx.doi.org/10.1016/j.abrep.2017.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800559/
https://www.ncbi.nlm.nih.gov/pubmed/29450233
http://dx.doi.org/10.1016/j.abrep.2017.05.001

Ejemplares similares